Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
BioProcess Internation...BioProcess International US West
Not Confirmed
Not Confirmed
09-11 March, 2026
BioProcess Internation...BioProcess International
Not Confirmed
Not Confirmed
09-11 March, 2026
Not Confirmed
Not Confirmed
09-11 March, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS





Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
BioProcess Internation...BioProcess International US West
Industry Trade Show
Not Confirmed
09-11 March, 2026
BioProcess Internation...BioProcess International
Industry Trade Show
Not Confirmed
09-11 March, 2026
Industry Trade Show
Not Confirmed
09-11 March, 2026
Digital content

04 Mar 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/03/04/3249714/0/en/Aquestive-Therapeutics-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Provides-Business-Update.html

25 Feb 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/02/25/3244447/0/en/Aquestive-Therapeutics-to-Participate-in-Upcoming-March-Investor-Conferences.html

24 Feb 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/02/24/3243338/0/en/Aquestive-Therapeutics-to-Report-Fourth-Quarter-2025-Financial-Results-and-Recent-Business-Highlights-on-March-4-and-Host-Conference-Call-on-March-5-at-8-00-a-m-ET.html

23 Feb 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/02/23/3242467/0/en/Aquestive-Therapeutics-to-Participate-in-Oppenheimer-36th-Annual-Healthcare-Life-Sciences-Conference.html

18 Feb 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/02/18/3240054/0/en/Aquestive-Therapeutics-Appoints-Internationally-Recognized-Allergist-Dr-Matthew-Greenhawt-as-Chief-Medical-Officer.html

02 Feb 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/02/02/3230115/0/en/Aquestive-Therapeutics-Announces-FDA-Issuance-of-Complete-Response-Letter-for-Anaphylm.html
ABOUT THIS PAGE